Evidence map›Paper›PMID 41716864›Full record

ArticleInternational journal of endocrinology and metabolism2025

The Modulatory Effects of

Farzaneh Hasanian-Langroudi, Mehdi Hedayati, Asghar Ghasemi, Seyed Davar Siadat, Maryam Tohidi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Farzaneh Hasanian-LangroudiPrevention of Metabolic Disorders Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-4093-4911
Mehdi HedayatiCellular and Molecular Endocrine Research Center, Research Institute for Endocrine Molecular Biology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-5816-775X
Asghar GhasemiEndocrine Physiology Research Center, Research Institute for Endocrine Molecular Biology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-6867-2151
Seyed Davar SiadatDepartment of Mycobacteriology and Pulmonary Research, Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0000-0002-6892-5603
Maryam TohidiPrevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-3090-9904

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a prevalent disorder with significant complications and mortality. Gut microbiota plays a role in metabolic homeostasis, and dysbiosis may contribute to inflammation and insulin resistance (IR). Objectives: This study aimed to investigate the effect of Methods: Thirty-two male Wistar rats were randomly assigned to normal control groups or a high-fat diet/streptozotocin-induced T2DM group. Each group received 5-week oral Results: Compared to the T2DM-PBS group, administration of Conclusions:

Indexed as

Bacteroides thetaiotaomicronEndocannabinoid ReceptorsGut MicrobiotaRat ModelType 2 Diabetes Mellitus

Identifiers

PMID41716864
PMCPMC12915503

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.